Procedure Volume Patient Data Patient Conditions Reviews General Payments Back to Top

Home > TN Providers

Dr. Meredith Ann McKean, MD

(No ratings)

Specializes in: Medical Oncology, Adult Oncology and Adult Hematology

University of Iowa, Carver College of Medicine (2012)

335 24th Avenue North Suite 200
Nashville, TN 37203

(615) 329-7640

Dr. Meredith Ann McKean, MD is a medical oncologist in Nashville, TN specializing in medical oncology, adult oncology and adult hematology. She graduated from University of Iowa, Carver College of Medicine in 2012 and has 14 years of experience. Dr. Meredith Ann McKean, MD is affiliated with TriStar Health, Williamson Health, Ascension, Ascension Saint Thomas Hospital Midtown, VERDI ONCOLOGY TENNESSEE PC and TriStar Centennial Medical Center Sarah Cannon Cancer Institute.

Office Locations

250 25th Avenue N Suite 200
Nashville, TN 37203

(615) 986-4366

(615) 320-1617

open_in_new

TriStar Centennial Medical Center Sarah Cannon Cancer Institute

335 24th Avenue North Suite 200
Nashville, TN 37203

(615) 329-7640

open_in_new

4488 Carothers Parkway
Franklin, TN 37067

open_in_new

In The News

“In 2024, the first cellular therapy, Lifileucel, was approved in melanoma after decades of research, according to Meredith McKean, M.D., of the Sarah Cannon Research Institute (not pictured).”—"The year in cancer: Advances made in 2024, predictions for 2025", Fox News, December 2024

“"My hope is that if we're successful, we'll be able to move into more tumor types where checkpoints haven't been as successful," said Meredith McKean, Fentress' oncologist at Sarah Cannon Research...”—"The same mRNA technology used in COVID-19 vaccines could help treat cancer", USA Today, June 2021

Noteworthy Medicare Patient Procedures Performed by Dr. Meredith Ann McKean, MD in 2023

Click on any procedure below to see further details on volume and pricing among Medicare patients.

Top 5%

By Affordability:

hospital care

inpatient care

inpatient hospital care

magnesium test

In 2023, Dr. Meredith Ann McKean, MD had a list price for hospital care, inpatient care, inpatient hospital care (for patient admitted to hospital), and magnesium test that was lower than the list prices billed to Medicare by 95% of providers in related specialties within Tennessee. Actual amounts paid by patients can vary widely depending on a number of factors, including insurance coverage. A lower list price, however, might mean lower fees when paying without insurance.

Top 10%

By Affordability:

liver function tests

In 2023, Dr. Meredith Ann McKean, MD had a list price for liver function tests (LFTs) that was lower than the list prices billed to Medicare by 90% of providers in related specialties within Tennessee. Actual amounts paid by patients can vary widely depending on a number of factors, including insurance coverage. A lower list price, however, might mean lower fees when paying without insurance.

Top 25%

By Volume:

phosphorus blood test

By Affordability:

blood tests

lab tests

In 2013, among providers in related specialties within Tennessee, Dr. Meredith Ann McKean, MD performed more phosphorus blood test procedures for Medicare patients than 75% of them and she also had a list price for blood tests, and lab tests that was lower than the list prices billed to Medicare by 75% of them. Actual amounts paid by patients can vary widely depending on a number of factors, including insurance coverage. A lower list price, however, might mean lower fees when paying without insurance.

Medicare Procedure and Patient Information

2018 Medicare Procedure Volume

The top procedures that Dr. Meredith Ann McKean, MD treated as a medical oncologist in Nashville, TN during 2018 were chemotherapy, biological response modifier (BRM) therapy and minimally invasive procedures.

Volume of procedures performed by Dr. Meredith Ann McKean, MD for Medicare patients.

biological response modifier (BRM) therapy	21
chemotherapy	21
minimally invasive procedures	21

2018 Medicare Patient Data

Information about Medicare patients treated by Dr. Meredith Ann McKean, MD.

**Gender**
Male	17
Female	25

**Age**
From 65 to 74	26
From 75 to 84	0
85 and over	0
Less than 65	0

Conditions of Medicare patients treated by Dr. Meredith Ann McKean, MD in 2018

The most common conditions of Medicare patients that Dr. Meredith Ann McKean, MD treated during 2018 were hypertension, cancer and chronic kidney disease.

Hypertension	55
High Cholesterol	0
Stroke	0
Ischemic Heart Disease	0
Depression	0
Chronic Kidney Disease	40
Asthma	0
Osteoperosis	0
Atrial Fibrilation	0
Heart Failure	0
Chronic Obstructive Pulmonary Disease	0
Diabetes	0
Dementia	0
Cancer	48

Medicare Procedure and Patient Information

2019 Medicare Procedure Volume

The top procedures that Dr. Meredith Ann McKean, MD treated as a medical oncologist in Nashville, TN during 2019 were lab tests, minimally invasive procedures, chemotherapy and biological response modifier (BRM) therapy.

Volume of procedures performed by Dr. Meredith Ann McKean, MD for Medicare patients.

biological response modifier (BRM) therapy	268
blood draw	71
chemotherapy	268
doctor visit	378
hospital care	114
inpatient care	114
lab tests	3569
minimally invasive procedures	286
preventive care	12
vaccines	12

2019 Medicare Patient Data

Information about Medicare patients treated by Dr. Meredith Ann McKean, MD.

**Gender**
Male	115
Female	138

**Ethnicity**
Non-Hispanic White	227
Black	0
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	136
From 75 to 84	65
85 and over	0
Less than 65	0

Conditions of Medicare patients treated by Dr. Meredith Ann McKean, MD in 2019

The most common conditions of Medicare patients that Dr. Meredith Ann McKean, MD treated during 2019 were hypertension, cancer, chronic kidney disease and high cholesterol.

Hypertension	56
High Cholesterol	41
Stroke	6
Ischemic Heart Disease	27
Depression	24
Chronic Kidney Disease	42
Asthma	4
Osteoperosis	4
Atrial Fibrilation	10
Heart Failure	14
Chronic Obstructive Pulmonary Disease	11
Diabetes	27
Dementia	4
Cancer	49

Medicare Procedure and Patient Information

2020 Medicare Procedure Volume

The top procedures that Dr. Meredith Ann McKean, MD treated as a medical oncologist in Nashville, TN during 2020 were lab tests, minimally invasive procedures, chemotherapy and biological response modifier (BRM) therapy.

Volume of procedures performed by Dr. Meredith Ann McKean, MD for Medicare patients.

biological response modifier (BRM) therapy	300
blood draw	226
chemotherapy	300
doctor visit	661
hospital care	99
inpatient care	99
lab tests	5366
minimally invasive procedures	324
thyroid function tests	72

2020 Medicare Patient Data

Information about Medicare patients treated by Dr. Meredith Ann McKean, MD.

**Gender**
Male	126
Female	151

**Ethnicity**
Non-Hispanic White	245
Black	21
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	149
From 75 to 84	73
85 and over	0
Less than 65	0

Conditions of Medicare patients treated by Dr. Meredith Ann McKean, MD in 2020

The most common conditions of Medicare patients that Dr. Meredith Ann McKean, MD treated during 2020 were hypertension, cancer, chronic kidney disease and high cholesterol.

Hypertension	55
High Cholesterol	36
Stroke	4
Ischemic Heart Disease	27
Depression	24
Chronic Kidney Disease	38
Asthma	0
Osteoperosis	0
Atrial Fibrilation	8
Heart Failure	13
Chronic Obstructive Pulmonary Disease	6
Diabetes	25
Dementia	4
Cancer	39

Medicare Procedure and Patient Information

2021 Medicare Procedure Volume

The top procedures that Dr. Meredith Ann McKean, MD treated as a medical oncologist in Nashville, TN during 2021 were lab tests, minimally invasive procedures, chemotherapy and biological response modifier (BRM) therapy.

Volume of procedures performed by Dr. Meredith Ann McKean, MD for Medicare patients.

biological response modifier (BRM) therapy	344
blood draw	233
chemotherapy	344
doctor visit	657
hospital care	94
inpatient care	94
lab tests	5705
minimally invasive procedures	363
thyroid function tests	123

2021 Medicare Patient Data

Information about Medicare patients treated by Dr. Meredith Ann McKean, MD.

**Gender**
Male	159
Female	164

**Ethnicity**
Non-Hispanic White	291
Black	18
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	176
From 75 to 84	93
85 and over	0
Less than 65	0

Conditions of Medicare patients treated by Dr. Meredith Ann McKean, MD in 2021

The most common conditions of Medicare patients that Dr. Meredith Ann McKean, MD treated during 2021 were hypertension, cancer, high cholesterol and chronic kidney disease.

Hypertension	53
High Cholesterol	38
Stroke	5
Ischemic Heart Disease	26
Depression	23
Chronic Kidney Disease	34
Asthma	3
Osteoperosis	5
Atrial Fibrilation	13
Heart Failure	13
Chronic Obstructive Pulmonary Disease	10
Diabetes	23
Dementia	6
Cancer	44

Medicare Procedure and Patient Information

2022 Medicare Procedure Volume

The top procedures that Dr. Meredith Ann McKean, MD treated as a medical oncologist in Nashville, TN during 2022 were lab tests, blood draw, minimally invasive procedures and chemotherapy.

Volume of procedures performed by Dr. Meredith Ann McKean, MD for Medicare patients.

biological response modifier (BRM) therapy	211
blood draw	258
chemotherapy	211
doctor visit	394
hospital care	92
inpatient care	92
lab tests	2617
minimally invasive procedures	228
thyroid function tests	122

2022 Medicare Patient Data

Information about Medicare patients treated by Dr. Meredith Ann McKean, MD.

**Gender**
Male	118
Female	150

**Ethnicity**
Non-Hispanic White	240
Black	13
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	121
From 75 to 84	91
85 and over	0
Less than 65	0

Conditions of Medicare patients treated by Dr. Meredith Ann McKean, MD in 2022

The most common conditions of Medicare patients that Dr. Meredith Ann McKean, MD treated during 2022 were hypertension, cancer, high cholesterol and diabetes.

Hypertension	65
High Cholesterol	48
Stroke	6
Ischemic Heart Disease	20
Depression	21
Chronic Kidney Disease	23
Asthma	0
Osteoperosis	9
Atrial Fibrilation	13
Heart Failure	15
Chronic Obstructive Pulmonary Disease	11
Diabetes	25
Dementia	0
Cancer	49

Medicare Procedure and Patient Information

2023 Medicare Procedure Volume

The top procedures that Dr. Meredith Ann McKean, MD treated as a medical oncologist in Nashville, TN during 2023 were lab tests, chemotherapy, biological response modifier (BRM) therapy and minimally invasive procedures.

Volume of procedures performed by Dr. Meredith Ann McKean, MD for Medicare patients.

biological response modifier (BRM) therapy	247
blood draw	244
chemotherapy	247
doctor visit	559
hospital care	52
inpatient care	52
lab tests	1863
minimally invasive procedures	247
thyroid function tests	154

2023 Medicare Patient Data

Information about Medicare patients treated by Dr. Meredith Ann McKean, MD.

**Gender**
Male	150
Female	179

**Ethnicity**
Non-Hispanic White	296
Black	18
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	182
From 75 to 84	102
85 and over	15
Less than 65	30

Conditions of Medicare patients treated by Dr. Meredith Ann McKean, MD in 2023

The most common conditions of Medicare patients that Dr. Meredith Ann McKean, MD treated during 2023 were hypertension, high cholesterol, cancer and diabetes.

Hypertension	72
High Cholesterol	59
Stroke	9
Ischemic Heart Disease	25
Depression	16
Chronic Kidney Disease	22
Asthma	5
Osteoperosis	11
Atrial Fibrilation	15
Heart Failure	12
Chronic Obstructive Pulmonary Disease	13
Diabetes	29
Dementia	4
Cancer	44

Medicare Procedure and Patient Information

Average Medicare Procedure Volume From 2018 - 2023

Volume of procedures performed by Dr. Meredith Ann McKean, MD for Medicare patients.

The highest averages for the top procedures that Dr. Meredith Ann McKean, MD treated as a medical oncologist in Nashville, TN were lab tests, minimally invasive procedures, chemotherapy and biological response modifier (BRM) therapy.

biological response modifier (BRM) therapy	231
blood draw	206
chemotherapy	231
doctor visit	529
hospital care	90
inpatient care	90
lab tests	3824
minimally invasive procedures	244
preventive care	12
thyroid function tests	117
vaccines	12

Average Medicare Patient Data From 2018 - 2023

Information about Medicare patients treated by Dr. Meredith Ann McKean, MD.

**Gender**
Female	134
Male	114

**Ethnicity**
Black / African American	11
Asian / Pacific Islander	0
Non-Hispanic White	216
Native American / Alaskan Native	0
Hispanic	0
Other	0

**Age**
85 and over	2
75 to 84	70
Less than 65	5
65 to 74	131

Average of Total of Conditions of Medicare patients treated by Dr. Meredith Ann McKean, MD From 2018 - 2023

The highest averages of the most common conditions of Medicare patients that Dr. Meredith Ann McKean, MD treated were hypertension, cancer, high cholesterol and chronic kidney disease.

Hypertension	59
High Cholesterol	37
Stroke	5
Ischemic Heart Disease	20
Depression	18
Chronic Kidney Disease	33
Asthma	2
Osteoporosis	4
Heart Failure	11
Chronic Obstructive Pulmonary Disease	8
Diabetes	21
Atrial Fibrillation	9
Dementia	3
Cancer	45

Education & Training

Dr. Meredith Ann McKean, MD graduated from University of Iowa, Carver College of Medicine in 2012. She completed residency at University of Colorado Denver Affiliated Hospitals. She is certified by the Internal Medicine and has a state license in Texas.

Medical School: University of Iowa, Carver College of Medicine (2012)

Residency: University of Colorado Denver Affiliated Hospitals

Board Certification: Internal Medicine

Licensed In: Texas

Affiliations & Hospitals

Dr. Meredith Ann McKean, MD is associated with these hospitals and organizations:

TriStar Health

Williamson Health

Ascension

Ascension Saint Thomas Hospital Midtown

VERDI ONCOLOGY TENNESSEE PC

TriStar Centennial Medical Center Sarah Cannon Cancer Institute

Ratings & Reviews

Dr. Meredith Ann McKean, MD does not have any reviews yet, be the first to leave a review of Dr. Meredith Ann McKean, MD here: Leave a Review

(No ratings)

Leave a Review

General Payments

These charts describe general payments received by Dr. Meredith Ann McKean, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.

**Payments by Company**
Merck Sharp & Dohme LLC	$16,811 KEYTRUDA $1,910	$14,901
Regeneron Pharmaceuticals, Inc.	$9,331 LIBTAYO $9,331
ARRAY BIOPHARMA INC	$3,826 Braftovi $3,780	Mektovi $46
Regeneron Healthcare Solutions, Inc.	$2,437 LIBTAYO $2,437
EISAI INC.	$1,871 Lenvima $1,871
Other	$4,523 INLYTA $625	Non-Covered Product $548	OPDIVO $346	KIMMTRAK $322	EMPLICITI $138	Other $2,545

**Types of Payments**
Consulting Fee	$26,263
Food and Beverage	$4,731
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program	$3,780
Travel and Lodging	$3,362
Honoraria	$625
Other	$37

Research Payments

Dr. Meredith Ann McKean, MD has received 1397 research payments totaling $9,751,646.

Biography

Dr. Meredith McKean is a medical specialist in adult hematology, adult oncology, and medical oncology. She graduated from the University of Iowa, Carver College of Medicine and the University of Illinois College of Medicine and then she performed her residency at a hospital affiliated with the University of Colorado Denver. Dr. McKean is professionally affiliated with Ascension, Williamson Health, and TriStar Health.